The China market dominated the Asia Pacific Trypsin Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $9.19 million by 2031, growing at a CAGR of 4 % during the forecast period. The Japan market is registering a CAGR of 5.3% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 6.5% during (2024 - 2031).
Trypsin is extensively utilized in cell biology and regenerative medicine for tissue dissociation and cell isolation. By cleaving peptide bonds in extracellular matrix proteins, trypsin facilitates the dissociation of tissues into single cells or small cell clusters.
Moreover, this process is essential for isolating primary cells from various tissues and organs for subsequent culture, transplantation, or analysis. In stem cell research and tissue engineering, trypsin-mediated cell isolation is critical in generating functional tissue constructs for therapeutic applications.
The expansion of the biotechnology sector in India, particularly in areas such as pharmaceuticals and healthcare, is driving demand for biopharmaceutical products. Trypsin is a crucial enzyme in biologics production, including therapeutic proteins, monoclonal antibodies, and vaccines. As Indian biopharmaceutical companies expand their manufacturing capabilities to meet domestic and international demand, the demand for trypsin as a key enzyme in cell culture-based processes will likely increase.
List of Key Companies Profiled
- Merck Millipore (Merck KGaA)
- Novozymes A/S (Novo Holdings A/S)
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Takara Bio Inc. (Takara Holdings Inc.)
- Sartorius AG
- PromoCell GmbH
- Geno Technology, Inc.
- Bio-Rad Laboratories, Inc.
Market Report Segmentation
By Source- Bovine
- Porcine
- Others
- Biotechnology & Pharmaceutical Industry
- Food Industry
- Cosmetics & Personal Care
- Waste Treatment
- Others
- Industrial use
- Research
- Diagnostics
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Companies Mentioned
- Merck Millipore (Merck KGaA)
- Novozymes A/S (Novo Holdings A/S)
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Takara Bio Inc. (Takara Holdings Inc.)
- Sartorius AG
- PromoCell GmbH
- Geno Technology, Inc.
- Bio-Rad Laboratories, Inc.
Methodology
LOADING...